Combination therapy with a short-acting erythropoiesis-stimulating agent and epoetin beta pegol eliminated the need for blood transfusions in a hemodialysis patient with myelodysplastic syndrome-Reference-Cited by-同舟云学术

Combination therapy with a short-acting erythropoiesis-stimulating agent and epoetin beta pegol eliminated the need for blood transfusions in a hemodialysis patient with myelodysplastic syndrome

Published:2018 Issue:3 Volume:51 Page:235-242
ISSN:1340-3451
Container-title:Nihon Toseki Igakkai Zasshi
language:en
Short-container-title:Nihon Toseki Igakkai Zasshi

Author:

Tomomatsu Hideaki¹²,Nagamachi Seiji¹,Horikiri Tsugumi¹,Samejima Masatsugu¹,Samejima Mio³,Yano Takahiro⁴,Kitamura Makoto⁵

Affiliation:

1. Shomikai Sakurashinmachi Clinic

2. Shomikai Kanamachi Kidney Clinic

3. Department of Urology, Kyorin University Hospital

4. Department of Internal Medicine, Hematology, National Hospital Organization Tokyo Medical Center

5. Department of Internal Medicine, Nephrology, Teikyo University Chiba Medical Center

Publisher

Japanese Society for Dialysis Therapy

Subject

Organic Chemistry,Biochemistry

Link

https://www.jstage.jst.go.jp/article/jsdt/51/3/51_235/_pdf

Reference16 articles.

1. 6) Ozasa H. Transient Combination Therapy with Continuous Erythropoietin Receptor Activator (C.E.R.A.) and Epoetin Kappa for treatment of Renal Anemia in Hemodialysis Patients. Progress in Medicine 2013; 33: 599-605.

2. 9) Ohshima M, Ubara Y, Tagami T, et al. Long-term erythropoietin therapy improves response in myelodysplastic syndrome. Ther Apher Dial 2005; 9: 362-6.

3. 10) Shiraya K, Ubara Y, Katori H, et al. Recovery from aplastic anaemia after institution of haemodialysis. Nephrol Dial Transplant 2001; 16: 1726-8.

4. 11) Hellström-Lindberg E, Ahlgren T, Beguin Y, et al. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase Ⅱ study and long-term follow-up of 71 patients. Blood 1998; 92: 68-75.

5. 12) Hellström-Lindberg E, Negrin R, Stein R, et al. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br J Haematol 1997; 99: 344-51.